1 enrolling by invitation. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Ardelyx: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C Tenapanor - Irritable Bowel Syndrome With Constipation (IBS-C) | Phase 3 | Enrolling by invitation | Ardelyx | 150 | 2023-02-17 | 2026-06-04 |
tenapanor (1)
United States (1)
Jocelyn Tabora (1)